I. Résultats-de-l-'enquête and .. , 39 III.A. Caractéristiques de la population étudiée, p.39

I. Discussion and .. , 70 IV.A. Résultat principal et ses implications, p.70

I. C. Le-sport-comme-substitut and ?. , 88 IV.C.6.a. Existence d' un sous-groupe à risques parmi les sportifs, p.88

V. Annexes and .. , 105 VIII.A. Enquête sur la Réunion : questionnaire page 1, p.105

V. G. Test, A. Le, and D. , 111 VIII.H. Critères diagnostiques de l'abus selon, p.112

C. Turner, M. Elsohly, and E. Boeren, Constituents of Cannabis sativa L. XVII. A Review of the Natural Constituents, Journal of Natural Products, vol.43, issue.2, pp.169-234, 1980.
DOI : 10.1021/np50008a001

M. Earleywine and S. Barnwell, Decreased respiratory symptoms in cannabis users who vaporize, Harm Reduction Journal, vol.4, issue.1, p.11, 2007.
DOI : 10.1186/1477-7517-4-11

K. Hillig and P. Mahlberg, A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae), American Journal of Botany, vol.91, issue.6, pp.966-975, 2004.
DOI : 10.3732/ajb.91.6.966

M. Marks, L. Tian, J. Wenger, and S. Omburo, Identification of candidate genes affecting ??9-tetrahydrocannabinol biosynthesis in Cannabis sativa, Journal of Experimental Botany, vol.60, issue.13, pp.3715-3726, 2009.
DOI : 10.1093/jxb/erp210

C. Turner and K. Hadley, Constituents of Cannabis Sativa L. II: Absence of Cannabidiol in an African Variant, Journal of Pharmaceutical Sciences, vol.62, issue.2, pp.251-255, 1973.
DOI : 10.1002/jps.2600620214

J. Lydon, A. Teramura, and C. Coffman, UV-B RADIATION EFFECTS ON PHOTOSYNTHESIS, GROWTH and CANNABINOID PRODUCTION OF TWO Cannabis sativa CHEMOTYPES, Photochemistry and Photobiology, vol.25, issue.2, pp.201-206, 1987.
DOI : 10.1111/j.1399-3054.1983.tb04203.x

L. Petrocellis, M. Cascio, D. Marzo, and V. , The endocannabinoid system: a general view and latest additions, British Journal of Pharmacology, vol.400, issue.5, pp.765-774, 2004.
DOI : 10.1038/sj.bjp.0705666

R. Pertwee, -tetrahydrocannabivarin, British Journal of Pharmacology, vol.22, issue.2, pp.199-215, 2008.
DOI : 10.1038/sj.bjp.0707442

F. Leweke, D. Piomelli, F. Pahlisch, D. Muhl, C. Gerth et al., Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry.2012 mar, p.94

O. Devinsky, M. Cilio, H. Cross, J. Fernandez-ruiz, and J. French, Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders, Epilepsia, vol.69, issue.Suppl. 1, pp.791-802, 2014.
DOI : 10.1111/epi.12631

R. Mechoulam and L. Parker, Towards a better cannabis drug, British Journal of Pharmacology, vol.170, issue.7, pp.1363-1367, 2013.
DOI : 10.1111/bph.12400

P. Mukhopadhyay, M. Rajesh, B. Horváth, and S. Bátkai, Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death. Free Radical Biology and Medicine, pp.1368-1381, 2011.
DOI : 10.1016/j.freeradbiomed.2011.02.021

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988

G. Esposito, D. Filippis, D. Cirillo, C. Iuvone, and T. , Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview, Phytotherapy Research, vol.153, issue.5, pp.633-636, 2013.
DOI : 10.1002/ptr.4781

M. Bossong, B. Van-berckel, R. Boellaard, and L. Zuurman, Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum, NeuroImage, vol.41, issue.3, pp.759-66, 2009.
DOI : 10.1016/j.neuroimage.2008.04.231

T. Grieder, M. Herman, C. Contet, L. Tan, and H. Vargas-perez, VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation, Nature Neuroscience, vol.22, issue.12, pp.1751-1758, 2014.
DOI : 10.1016/S1046-2023(02)00220-7

Z. Sarnyai, Y. Shaham, and S. Heinrichs, The role of Corticotropin-Releasing Factor in drug addiction, Pharmacological Reviews, vol.53, issue.2, pp.209-244, 2001.

C. Galéra, M. Bouvard, M. Melchior, and J. Chastang, Disruptive symptoms in childhood and adolescence and early initiation of tobacco and cannabis use: The Gazel Youth study, European Psychiatry, vol.25, issue.7, pp.402-408, 2010.
DOI : 10.1016/j.eurpsy.2010.06.002

S. Blakemore, Teenage kicks cannabis and the adolescent brainRevue the lancet [en ligne], 2013.

D. Malone, M. Hill, and T. Rubino, Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models, British Journal of Pharmacology, vol.39, issue.3, pp.511-522, 2010.
DOI : 10.1111/j.1476-5381.2010.00721.x

C. Currie, C. Zanotti, A. Morgan, and D. Currie, Social determinants of health and well-being among young people.Health Behaviour in School-aged Children (HBSC) study: international report from the, survey, 2009.

D. Singly, C. Catteau, and C. , Etat de santé de la population de La Réunion et de Mayotte -Océan Indien, 2010.

B. Lakhdar, C. Godeau, E. Falissard, B. Jobard, F. Karsenty et al., Les drogues à 17 ans : situation dans les DOM, Tendances, vol.93, 2014.

C. Chen, O. Brien, M. Anthony, and J. , Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000???2001, Drug and Alcohol Dependence, vol.79, issue.1, pp.11-22, 2000.
DOI : 10.1016/j.drugalcdep.2004.11.014

M. Caffarel, C. Andradas, E. Pérez-gómez, and M. Guzmán, Cannabinoids: A new hope for breast cancer therapy?, Cancer Treatment Reviews, vol.38, issue.7, pp.911-918, 2012.
DOI : 10.1016/j.ctrv.2012.06.005

D. Bowles, The intersection between cannabis and cancer in the United States Critical Reviews in Oncology, Hematology, vol.83, pp.1-10, 2012.

A. Carracedo, Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids, Biochemical Journal, vol.380, issue.2, 2004.
DOI : 10.1042/bj20031714

J. Fernandez-ruiz, J. Romero, G. Velasco, and R. Tolon, Cannabinoid CB2 receptor: a new target for controlling neural cell survival? Trends in Pharmacological Sciences, pp.39-45, 2007.

B. Porter and C. Jacobson, Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy, Epilepsy & Behavior, vol.29, issue.3, pp.574-577, 2013.
DOI : 10.1016/j.yebeh.2013.08.037

J. Martínez-rodríguez, E. Munteis, M. Carreño, and Y. Blanco, Cannabis use in Spanish patients with multiple sclerosis: Fulfilment of patients' expectations?, Journal of the Neurological Sciences, vol.273, issue.1-2, 2008.
DOI : 10.1016/j.jns.2008.06.037

M. Nagarkatti, S. Rieder, V. Hegde, and S. Kanada, Do cannabinoids have a therapeutic role in transplantation? Trends in Pharmacological Sciences, pp.345-350, 2010.

L. Fattore, W. Fratta, and T. Beyond, The new generation of cannabinoid designer drugs, Front Behav Neurosci, vol.5, p.60, 2011.

R. Lindigkeit and . Spice, Spice: A never ending story?, Forensic Science International, vol.191, issue.1-3, pp.58-63, 2009.
DOI : 10.1016/j.forsciint.2009.06.008

S. Every-palmer, Synthetic cannabinoid JWH-018 and psychosis : An explorative study. Drug and Alcohol Dependence, pp.152-157, 2011.
DOI : 10.1016/j.drugalcdep.2011.01.012

N. Uchiyama, URB-754: A new class of designer drug and 12 synthetic cannabinoids detected in illegal products, Forensic Science International, vol.227, issue.1-3, pp.21-32, 2013.
DOI : 10.1016/j.forsciint.2012.08.047

K. Tomiyama, Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death, Toxicology and Applied Pharmacology, vol.274, issue.1, pp.17-23, 2014.
DOI : 10.1016/j.taap.2013.10.028

P. Fréour, . L. Un-tribunal-autorise-le-cannabis-thérapeutique, and . Figaro, Disponible sur http, 2013.

H. Afif, T. Urban, X. Quantin, and M. Abraham, L???association tabac-cannabis est-elle susceptible de modifier l???histoire naturelle de la d??pendance ?, Revue des Maladies Respiratoires Actualit??s, vol.2, issue.4, pp.376-385, 2010.
DOI : 10.1016/S1877-1203(10)70099-9

M. Underner, T. Urban, J. Perriot, and G. Peiffer, Usage du cannabis et retentissement fonctionnel respiratoire, Revue des Maladies Respiratoires, vol.30, issue.4, pp.272-285, 2013.
DOI : 10.1016/j.rmr.2013.01.013

D. Gieringer, S. Laurent, J. Goodrich, and S. , Cannabis Vaporizer Combines Efficient Delivery of THC with Effective Suppression of Pyrolytic Compounds, Journal of Cannabis Therapeutics, vol.23, issue.1, pp.7-27, 2004.
DOI : 10.1300/J175v03n01_04

N. Van-dam and M. Earleywine, Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer, International Journal of Drug Policy, vol.21, issue.6, pp.511-514, 2010.
DOI : 10.1016/j.drugpo.2010.04.001

M. Vallée, S. Vitiello, L. Bellocchio, and E. Hébert-chatelain, Pregnenolone Can Protect the Brain from Cannabis Intoxication, Science, vol.343, issue.6166, pp.94-98, 2014.
DOI : 10.1126/science.1243985

L. Breton-lerouvillois and G. , La démographie médicale en région DOM-TOM : Situation en 2013,Ordre des Médecins, 2014.

P. Fitzgerald, Elevated Norepinephrine May Be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine, Substance Abuse: Research and Treatment, vol.7, pp.171-83, 2013.
DOI : 10.4137/SART.S13019

L. Berre, E. Kerjean, and J. , Addiction chez l'adolescent. Journal de pédiatrie et de puériculture, pp.136-141, 2012.

A. Morral, D. Mccaffrey, and S. Paddock, Reassessing the marijuana gateway effect, Addiction, vol.74, issue.12, pp.1493-1504, 2002.
DOI : 10.1046/j.1360-0443.2002.00280.x

P. Gorwood, Le concept des addictions sous l'angle de la g??n??tique, Psychotropes, vol.14, issue.3, pp.29-39, 2008.
DOI : 10.3917/psyt.143.0029

L. Degenhardt, Evaluating the drug use ???gateway??? theory using cross-national data: Consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys, Drug and Alcohol Dependence, vol.108, issue.1-2, pp.84-97, 2010.
DOI : 10.1016/j.drugalcdep.2009.12.001

F. Beck, R. Guignard, I. Obradovic, A. Gautier, and L. Karila, Le d??veloppement du rep??rage des pratiques addictives en m??decine g??n??rale en France, Revue d'??pid??miologie et de Sant?? Publique, vol.59, issue.5, 2011.
DOI : 10.1016/j.respe.2011.03.059

D. Pageaud, Prévenir et prendre en charge l'usage problématique du cannabis : quelle est la place du médecin généraliste ?, 2004.

S. Spilka, E. Janssen, and S. Legleye, Détection des usages problematiques de cannabis : le Cannabis Abuse Screening Test (CAST) OFDT, pp.2013-2014, 2013.

M. H. Meier, A. Caspi, A. Amblere, and H. L. Harrington, Persistent cannabis users show neuropsychological decline from childhood to midlife, Proceedings of the National Academy of Sciences, vol.109, issue.40
DOI : 10.1073/pnas.1206820109

M. Fontes, Cannabis use before age 15 and subsequent executive functioning, The British Journal of Psychiatry, vol.198, issue.6, pp.442-447, 2011.
DOI : 10.1192/bjp.bp.110.077479

B. Becker, D. Wagner, E. Gouzoulis-mayfrank, E. Spuentrup, and J. Daumann, The impact of early-onset cannabis use on functional brain correlates of working memory. Progress in Neuro- Psychopharmacology and Biological Psychiatry, pp.837-845, 2010.

G. Davis, M. Compton, S. Wang, F. Levin, and C. Blanco, Association between cannabis use, psychosis, and schizotypal personality disorder: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions, Schizophrenia Research, vol.151, issue.1-3, pp.1-3197, 2013.
DOI : 10.1016/j.schres.2013.10.018

M. Auriacombe, M. Fatséas, L. Bec, P. Denis, C. Lavie et al., Cannabis et psychose : recherche d'un lien de causalité à partir d'une revue critique systématique de la littérature, Sept, vol.35, issue.4, pp.377-385, 2009.

M. Harley, I. Kelleher, M. Clarke, and F. Lynch, Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence, Psychological Medicine, vol.145, issue.10, pp.1627-1634, 2010.
DOI : 10.1016/0169-328X(93)90189-V

B. Laumon, B. Gadegbeku, and J. Martin, Stupéfiants et accidents mortels de la circulation routière ( projet SAM) Septembre Disponible sur http, 2005.

T. Urban, Manifestations respiratoires li??es ?? l???inhalation de fum??e de cannabis, Revue des Maladies Respiratoires, vol.25, issue.10, pp.1338-1378, 2008.
DOI : 10.1016/S0761-8425(08)75102-7

D. Tashkin, A. Coulson, V. Clark, and M. Simmons, Respiratory symptoms and lung function in habitual, heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone and non smokers, Am Rev Respir Dis, vol.135, pp.209-225, 1987.

H. Gong, S. Fligiel, D. Tashkin, and R. Barbers, Tracheobronchial Changes in Habitual, Heavy Smokers of Marijuana With and Without Tobacco, American Review of Respiratory Disease, vol.136, issue.1, pp.142-151, 1987.
DOI : 10.1164/ajrccm/136.1.142

S. Aldington, Effects of cannabis on pulmonary structure, function and symptoms, Thorax, vol.62, issue.12, pp.1058-63, 2007.
DOI : 10.1136/thx.2006.077081

B. Dautzenberg, Séminaire FMC Pneumologie et substances addictives inhalées : les enjeux Revue des Maladies Respiratoires, pp.1335-1337, 2008.

M. Underner, T. Urban, J. Perriot, G. Peiffer, and J. Meurice, Usage du cannabis et retentissement fonctionnel respiratoire, Revue des Maladies Respiratoires, vol.30, issue.4, pp.272-285, 2013.
DOI : 10.1016/j.rmr.2013.01.013

L. Karila, T. Danel, S. Coscas, and J. Chambon, L'artérite progressive cannabique, un sous-type clinique de la thromboangéite oblitérante ? La Presse Médicale, pp.21-23, 2004.

M. Barbieux, O. Véran, and O. Detante, Accidents vasculaires cérébraux ischémiques du sujet jeune et toxiques .La Revue de médecine interne, pp.35-40, 2012.

B. Horváth, P. Mukhopadhyay, G. Haskó, and P. Pacher, The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications The American Journal of Pathology, Feb, vol.180, issue.2, 2012.

E. Jouanjus, M. Lapeyre-mestre, and J. Micallef, Cannabis Use: Signal of Increasing Risk of Serious Cardiovascular Disorders, Journal of the American Heart Association, vol.3, issue.2, 2014.
DOI : 10.1161/JAHA.113.000638

P. Guilbert and A. Gautier, Baromètre santé Attitudes et comportements de santé.INPES Disponible sur http, 2005.

P. Franques, M. Auriacombe, E. Piquemal, and M. Verger, Sensation seeking as a common factor in opioid dependent subjects and high risk sport practicing subjects. A cross sectional study. Drug and Alcohol Dependence, pp.121-126, 2003.

D. Mété, M. Ricquebourg, C. Bernède-bauduin, and C. Dafreville, Internet et jeux vidéo chez les étudiants de La Réunion en 2010 : usages, mésusages, perceptions et facteurs associés. Revue d'Épidémiologie et de Santé Publique, pp.503-512, 2013.

E. Bosc, M. Fatséas, J. Alexandre, and M. Auriacombe, Similitudes et diff??rences entre le jeu pathologique et la d??pendance aux substances??: qu???en est-il???, L'Enc??phale, vol.38, issue.5, pp.433-439, 2012.
DOI : 10.1016/j.encep.2012.02.004

G. Bouju, J. Hardouin, M. Grall-bronnec, and M. Auriacombe, Les joueurs de poker : un profil différent des autres joueurs ? European Psychiatry, pp.1-10, 2013.

M. Auriacombe, F. Serre, M. Fatseas, and J. Swendsen, Relation entre problèmes de sommeil et envie de consommer (craving) chez des sujets dépendants en début de prise en charge pour leur addiction, Médecine du Sommeil, p.34, 2014.

G. Van-de-glind, M. Konstenius, M. Koeter, and K. Van-emmerik-van-oortmerssen, Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: Results from an international multi-center study exploring DSM-IV and DSM-5 criteria, Drug and Alcohol Dependence, vol.134, pp.158-166, 2014.
DOI : 10.1016/j.drugalcdep.2013.09.026

G. Van-de-glind, W. Van-den-brink, M. Koeter, and P. Carpentier, Validity of the Adult ADHD Self- Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug and Alcohol Dependence, pp.587-596, 2013.

M. Bouvard, C. Blondeau, J. Rénéric, and C. Martin-guehl, Le trouble déficit de l'attention/hyperactivité à l'âge adulte : concept, tableau clinique, stratégies diagnostiques et thérapeutiques. Annales Médicopsychologiques , revue psychiatrique, pp.234-242, 2009.

S. Bioulac, L. Arfi, and M. Bouvard, Attention deficit/hyperactivity disorder and video games: A comparative study of hyperactive and control children, European Psychiatry, vol.23, issue.2, pp.134-175, 2008.
DOI : 10.1016/j.eurpsy.2007.11.002

L. Karila, S. Legleye, F. Beck, and E. Corruble, Validation d'un questionnaire de??rep??rage de??l'usage nocif d'alcool et??de??cannabis dans??la??population g??n??rale: le??CRAFFT-ADOSPA, La Presse M??dicale, vol.36, issue.4, pp.582-590, 2007.
DOI : 10.1016/j.lpm.2007.01.005

J. Bushnell, R. Gellatly, G. Hermansson, R. Mccormick, and . Guidelines-for-recognising, Assessing and Treating Alcohol and Cannabis Abuse in Primary Care, National Health Committee, 1999.

R. Et-sanctions-sur-le-cannabis-au-volant, Article L235-1 du code de la route modifié par Loi n°2007-297 du 5 mars Disponible sur http, 2007.

R. Courtois, C. Réveillère, A. Paüs, L. Berton, and C. Jouint, Liens entre stresseurs, sant?? psychique et premi??res consommations de tabac et d???alcool ?? la pr??adolescence, L'Enc??phale, vol.33, issue.3, pp.300-309, 2007.
DOI : 10.1016/S0013-7006(07)92043-6

P. Laure, T. Lecerf, L. Scanff, and C. , Les motivations ?? la consommation de produits dangereux sont-elles li??es au nombre de substances utilis??es??? Enqu??te aupr??s de 840??adolescents scolaris??s, Archives de P??diatrie, vol.8, issue.1, pp.16-24, 2001.
DOI : 10.1016/S0929-693X(00)00161-5

A. C. Campos, F. R. Ferreira, and F. S. Guimarães, Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors Journal of Psychiatric Research, pp.1501-1510, 2012.

V. Micale, D. Marzo, V. Sulcova, A. Wotjak, C. T. Drago et al., Endocannabinoid system and mood disorders: Priming a target for new therapies, Pharmacology & Therapeutics, vol.138, issue.1, pp.18-37
DOI : 10.1016/j.pharmthera.2012.12.002

J. Pan, Le médecin généraliste face à la consommation de cannabis [thèse de doctorat de médecine], 2007.

F. Guénolé, N. A. Hommeril, A. Davidsen, C. Baleyte, and J. , Sommeil et substances ?? l???adolescence??: les effets de la caf??ine, de l???alcool, du tabac et du cannabis, M??decine du Sommeil, vol.8, issue.4, pp.152-158, 2011.
DOI : 10.1016/j.msom.2011.09.001

D. Ford, H. Vu, and J. Anthony, Marijuana use and cessation of tobacco smoking in adults from a community sample. Drug alcohol depend, pp.243-251, 2002.

. Drogues-info-service, Carte des structures Réunionaises pour l'accueuil et de soins pour les conduites addictives Disponible sur http, 2014.

L. Blecha, A. Benyamina, and M. Reynaud, Le cannabis chez l???adolescent??: prise en charge par les familles, Archives de P??diatrie, vol.17, issue.2, pp.191-194, 2010.
DOI : 10.1016/j.arcped.2009.09.018

J. O. Prochaska, C. C. Diclemente, . Norcross, and C. John, In search of how people change: Applications to addictive behaviors., American Psychologist, vol.47, issue.9, pp.1102-1114, 1992.
DOI : 10.1037/10248-026

S. Rollnick and W. Miller, What is Motivational Interviewing? Behavioural and cognitive psychotherapy, pp.325-334, 1995.

E. De-gee, J. Verdurmen, E. Bransen, and J. De-jonge, A randomized controlled trial of a brief motivational enhancement for non-treatment-seeking adolescent cannabis users, Journal of Substance Abuse Treatment, vol.47, issue.3, pp.181-188, 2014.
DOI : 10.1016/j.jsat.2014.05.001

R. Rodenburg, A. Benjamin, C. De-roos, and A. Meijer, Efficacy of EMDR in children: A meta-analysis, Clinical Psychology Review, vol.29, issue.7, pp.599-606, 2009.
DOI : 10.1016/j.cpr.2009.06.008

M. Ho and C. Lee, Thérapie cognitivo-comportementale et eye movement desensitization and reprocessing (EMDR) dans la prise en charge de l'état de stress post-traumatique ? la différence n'estelle due qu'aux exercices que l'on demande aux patients de réaliser chez eux ? Revue Européenne de Psychologie Appliquée, pp.253-260, 2012.

P. Franques, M. Auriacombe, and J. Tignol, Sport, dopage et addictions: Délimitations conceptuelles et approche épidémiologique à partir des données de la littérature, Annales de médecine interne, vol.152, issue.7, pp.2-37, 2001.

E. Volle and J. Seznec, L'arrêt du sport intensif : révélation d'addictions ? Annales Médicopsychologiques, pp.775-779, 2006.
DOI : 10.1016/j.amp.2006.08.001

W. Lowenstein, P. Arvers, L. Gourarier, and A. Porche, Activités physiques et sportives dans les antécédents des personnes prises en charge pour addictions. Rapport 1999 de l'étude commanditée par le Ministère de la Jeunesse et des Sports, Annales de Médecine Interne, vol.151, pp.18-26, 2000.

R. Ryan and E. Deci, Intrinsic and Extrinsic Motivations: Classic Definitions and New Directions, Contemporary Educational Psychology, vol.25, issue.1, pp.54-67, 2000.
DOI : 10.1006/ceps.1999.1020

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.318.808

M. Maugendre, E. Spitz, and . Mai, Consommation de cannabis et motivation sportiveBulletin de psychologie, pp.477-484, 2008.

. Drogues-info-service, campagne de prevention contre le cannabis, 2014.

C. Général-de-la-réunion, campagne de sensibilisation sur le zamal, (page consultée le 10 Disponible sur http, 2014.

A. Mercier, L. Letrilliart, I. Supper, and M. Schuers, ECOGEN : étude des Éléments de la COnsultation en médecine GENérale, Exercer, vol.114, pp.148-57, 2014.